tm logo
ELIMSA
Live/Registered
REGISTERED

on 07 Mar 2023

Last Applicant/ Owned by

Toronto ON M4T 1K4

CA

Serial Number

79312543 filed on 18th Feb 2021

Registration Number

6993636 registered on 07th Mar 2023

in the Principal Register

Correspondent Address

NICOLE K. MCLAUGHLIN

Nicole K. McLaughlin DUANE MORRIS LLP

Philadelphia, PA 19103-4196

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

ELIMSA

Diagnostic and test kits, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic and test kits, namely, drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids for the presence of protein, DNA, RNA, antibody, nanobody, aptamer, peptide, and biopolymer; Diagnostic and test kits, namely Read More

Classification Information


Class [009]
Computer & Software Products & Electrical & Scientific Products


Laboratory and scientific equipment for diagnostic testing and medical treatment, namely, test tubes, microscope slides, incubators, laboratory robots, and chromatography supports being chromatography apparatus for laboratory use; Laboratory and scientific equipment for diagnostic testing and medical treatment, namely, diagnostic apparatus for the detection of pathogens for laboratory or research use; Laboratory and scientific equipment for diagnostic testing and medical treatment, namely, medical diagnostic simulators for use as teaching aids for detecting pathogens, DNA analysis, and chromatography; electrophoresis laboratory apparatus and instruments for extracting biomolecules within enzyme-linked immunosorbent assays, immunoblots, polymerase chain reactions (PCR), hybridization, binding assays, nucleic acids, DNA, RNA, proteins, and antigens, not for medical purposes; analytical apparatus in the nature of an automated slide stainer for use in medical laboratories; and replacement parts and fittings therefor


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Diagnostic and test kits, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic and test kits, namely, drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids for the presence of protein, DNA, RNA, antibody, nanobody, aptamer, peptide, and biopolymer; Diagnostic and test kits, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious diseases, oncology being cancers, neurological diseases, immunological diseases, cardiovascular diseases, genetic diseases, environmental diseases, dietary diseases, and pathogens; diagnostic reagents for medicinal use; medical diagnostic reagents; Kits for testing of body fluids, namely, medical diagnostic reagents and assays for testing body fluids, tissues or cells for microorganisms; Kits for testing of body fluids, namely, medical diagnostic reagents and assays for testing of body fluids and tissue of cells for human health, capture and detection reagents for environmental use, human health, agriculture, food and nutrition; laboratory and scientific equipment for detection, quantification of analytes, biopolymers or germs, and diagnosis of virus, disease and pathogens, namely, diagnostic media for bacteriological cultures, medical diagnostic test media in the form of strip, threads, multi-well plates, microbeads, nanobeads, for measuring pathological condition, phenotypic condition, genotypic condition; and replacement parts and fittings therefor


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79312543

Mark Type

No Service/Collective Mark

Attorney Docket Number

No H3780-00024

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
18th Oct 2024NEW REPRESENTATIVE AT IB RECEIVED
03rd Jul 2023FINAL DECISION TRANSACTION PROCESSED BY IB
12th Jun 2023FINAL DISPOSITION PROCESSED
12th Jun 2023FINAL DISPOSITION NOTICE SENT TO IB
07th Jun 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07th Mar 2023REGISTERED-PRINCIPAL REGISTER
07th Mar 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
21st Dec 2022NOTIFICATION PROCESSED BY IB
20th Dec 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20th Dec 2022PUBLISHED FOR OPPOSITION